ITGAM and tuberculosis: CY+TLRa treatment generated CD11b+Gr1dim tumoricidal precursors even in naïve non-TB mice (Figure 7), confirming that this is a direct impact on normal host cells rather than an indirect effect resulting from tumor cytoreduction.